Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
1
|
Orthohantavirus
|
359,554
|
11,598
|
B
|
Top
|
2
|
Hantavirus pulmonary syndrome
|
311,049
|
10,033
|
B
|
High
|
3
|
Measles
|
248,784
|
8,025
|
B
|
Top
|
4
|
COVID-19 pandemic
|
246,690
|
7,957
|
GA
|
Top
|
5
|
Norovirus
|
221,569
|
7,147
|
B
|
Top
|
6
|
COVID-19
|
154,545
|
4,985
|
B
|
Top
|
7
|
Prion
|
121,515
|
3,919
|
GA
|
Top
|
8
|
Smallpox
|
109,596
|
3,535
|
GA
|
Top
|
9
|
Rabies
|
108,486
|
3,499
|
B
|
Top
|
10
|
Shingles
|
108,038
|
3,485
|
GA
|
Top
|
11
|
List of epidemics and pandemics
|
101,434
|
3,272
|
List
|
High
|
12
|
HIV/AIDS
|
98,699
|
3,183
|
GA
|
Top
|
13
|
Spanish flu
|
96,596
|
3,116
|
GA
|
Top
|
14
|
Human papillomavirus infection
|
94,399
|
3,045
|
B
|
Top
|
15
|
Respiratory syncytial virus
|
85,684
|
2,764
|
B
|
High
|
16
|
Epstein–Barr virus
|
82,222
|
2,652
|
B
|
Top
|
17
|
Polio
|
67,535
|
2,178
|
B
|
Top
|
18
|
Canine parvovirus
|
67,378
|
2,173
|
B
|
Top
|
19
|
Chickenpox
|
65,341
|
2,107
|
B
|
Top
|
20
|
Virus
|
64,571
|
2,082
|
FA
|
Top
|
21
|
HIV
|
63,723
|
2,055
|
GA
|
Top
|
22
|
Creutzfeldt–Jakob disease
|
60,943
|
1,965
|
B
|
Top
|
23
|
Infectious mononucleosis
|
60,651
|
1,956
|
B
|
Top
|
24
|
COVID-19 pandemic in the United States
|
55,450
|
1,788
|
B
|
Low
|
25
|
Hodgkin lymphoma
|
53,524
|
1,726
|
B
|
Top
|
26
|
Gastroenteritis
|
53,376
|
1,721
|
GA
|
Top
|
27
|
Molluscum contagiosum
|
53,208
|
1,716
|
B
|
High
|
28
|
Rosalind Franklin
|
51,823
|
1,671
|
B
|
High
|
29
|
Dengue fever
|
50,512
|
1,629
|
FA
|
Top
|
30
|
Herpes
|
48,721
|
1,571
|
GA
|
Top
|
31
|
Influenza
|
47,735
|
1,539
|
FA
|
High
|
32
|
Bell's palsy
|
46,621
|
1,503
|
B
|
Top
|
33
|
Rubella
|
45,060
|
1,453
|
B
|
Top
|
34
|
Influenza A virus
|
43,191
|
1,393
|
B
|
Top
|
35
|
Mumps
|
41,692
|
1,344
|
B
|
Top
|
36
|
COVID-19 lockdown in India
|
41,220
|
1,329
|
B
|
Mid
|
37
|
Measles resurgence in the United States
|
40,606
|
1,309
|
C
|
Low
|
38
|
Influenza B virus
|
40,164
|
1,295
|
C
|
High
|
39
|
Herpes simplex virus
|
39,949
|
1,288
|
B
|
Top
|
40
|
Measles vaccine
|
39,885
|
1,286
|
C
|
Low
|
41
|
Hand, foot, and mouth disease
|
38,715
|
1,248
|
B
|
High
|
42
|
Timeline of the COVID-19 pandemic
|
38,564
|
1,244
|
List
|
Top
|
43
|
Rotavirus
|
37,844
|
1,220
|
FA
|
Top
|
44
|
SARS-CoV-2
|
37,822
|
1,220
|
B
|
Top
|
45
|
Ebola
|
35,778
|
1,154
|
B
|
Top
|
46
|
Chronic wasting disease
|
35,638
|
1,149
|
C
|
Top
|
47
|
COVID-19 lab leak theory
|
35,511
|
1,145
|
B
|
Low
|
48
|
Foot-and-mouth disease
|
34,662
|
1,118
|
B
|
High
|
49
|
Yellow fever
|
33,866
|
1,092
|
B
|
Top
|
50
|
Coronavirus
|
30,017
|
968
|
C
|
High
|
51
|
Croup
|
29,379
|
947
|
GA
|
Top
|
52
|
Hepatitis C
|
28,869
|
931
|
GA
|
Top
|
53
|
COVID-19 lockdowns
|
28,609
|
922
|
B
|
Low
|
54
|
Common cold
|
28,512
|
919
|
GA
|
Top
|
55
|
COVID-19 vaccine
|
27,704
|
893
|
C
|
Top
|
56
|
Bacteriophage
|
27,472
|
886
|
B
|
Top
|
57
|
Rhinovirus
|
26,835
|
865
|
C
|
High
|
58
|
Variant Creutzfeldt–Jakob disease
|
26,331
|
849
|
B
|
High
|
59
|
History of HIV/AIDS
|
26,109
|
842
|
B
|
Top
|
60
|
Hepatitis B
|
25,803
|
832
|
GA
|
Top
|
61
|
HeLa
|
25,301
|
816
|
C
|
Mid
|
62
|
COVID-19 pandemic deaths
|
24,853
|
801
|
C
|
Low
|
63
|
COVID-19 pandemic by country and territory
|
24,754
|
798
|
List
|
Top
|
64
|
Avian influenza
|
24,753
|
798
|
B
|
High
|
65
|
Vaccine
|
24,590
|
793
|
B
|
Top
|
66
|
Cytomegalovirus
|
24,573
|
792
|
B
|
Top
|
67
|
COVID-19 pandemic in India
|
23,069
|
744
|
B
|
High
|
68
|
Origin of SARS-CoV-2
|
22,813
|
735
|
C
|
Mid
|
69
|
Genital wart
|
22,166
|
715
|
B
|
Top
|
70
|
Cold sore
|
21,825
|
704
|
C
|
Top
|
71
|
Pandemic
|
21,225
|
684
|
B
|
High
|
72
|
Smallpox vaccine
|
20,785
|
670
|
B
|
Mid
|
73
|
Genital herpes
|
20,634
|
665
|
C
|
High
|
74
|
Kaposi's sarcoma
|
20,539
|
662
|
C
|
Mid
|
75
|
Zidovudine
|
20,015
|
645
|
B
|
High
|
76
|
Chikungunya
|
19,854
|
640
|
B
|
High
|
77
|
Edward Jenner
|
19,523
|
629
|
B
|
High
|
78
|
2025 Southwest United States measles outbreak
|
19,224
|
620
|
Start
|
Low
|
79
|
Human metapneumovirus
|
18,787
|
606
|
C
|
High
|
80
|
Subacute sclerosing panencephalitis
|
18,734
|
604
|
C
|
Mid
|
81
|
Cervical cancer
|
18,439
|
594
|
B
|
High
|
82
|
Varicella zoster virus
|
18,422
|
594
|
C
|
High
|
83
|
Epidemiology of HIV/AIDS
|
18,098
|
583
|
C
|
High
|
84
|
Great Barrington Declaration
|
17,951
|
579
|
B
|
Low
|
85
|
HPV vaccine
|
17,814
|
574
|
B
|
High
|
86
|
SARS
|
17,763
|
573
|
C
|
Top
|
87
|
Lassa fever
|
17,569
|
566
|
C
|
High
|
88
|
COVID-19 pandemic in the United Kingdom
|
17,494
|
564
|
C
|
Low
|
89
|
Varicella vaccine
|
17,280
|
557
|
B
|
Top
|
90
|
Hepatitis A
|
17,145
|
553
|
B
|
Top
|
91
|
Influenza A virus subtype H1N1
|
16,555
|
534
|
C
|
Top
|
92
|
List of COVID-19 vaccine authorizations
|
16,410
|
529
|
List
|
Mid
|
93
|
Hantavirus hemorrhagic fever with renal syndrome
|
16,116
|
519
|
B
|
High
|
94
|
Amantadine
|
16,009
|
516
|
C
|
High
|
95
|
Sore throat
|
15,971
|
515
|
C
|
High
|
96
|
Canine distemper
|
15,818
|
510
|
B
|
Top
|
97
|
Timeline of the COVID-19 pandemic in the United States (2020)
|
15,815
|
510
|
C
|
Low
|
98
|
List of deaths due to COVID-19
|
15,732
|
507
|
List
|
High
|
99
|
2009 swine flu pandemic
|
15,387
|
496
|
GA
|
High
|
100
|
Anti-vaccine activism
|
15,229
|
491
|
B
|
Low
|
101
|
Mpox
|
14,939
|
481
|
C
|
High
|
102
|
Marburg virus
|
14,911
|
481
|
C
|
High
|
103
|
COVID-19 misinformation
|
14,814
|
477
|
B
|
Low
|
104
|
Messenger RNA
|
14,225
|
458
|
C
|
High
|
105
|
Gardasil
|
14,202
|
458
|
B
|
High
|
106
|
1993 Four Corners hantavirus outbreak
|
14,085
|
454
|
B
|
High
|
107
|
Operation Warp Speed
|
13,421
|
432
|
C
|
High
|
108
|
Rinderpest
|
13,072
|
421
|
B
|
High
|
109
|
Antiviral drug
|
12,986
|
418
|
C
|
Top
|
110
|
2002–2004 SARS outbreak
|
12,859
|
414
|
B
|
Mid
|
111
|
Remdesivir
|
12,631
|
407
|
C
|
High
|
112
|
West Nile virus
|
12,566
|
405
|
B
|
High
|
113
|
History of smallpox
|
12,463
|
402
|
C
|
Mid
|
114
|
Influenza A virus subtype H5N1
|
12,315
|
397
|
B
|
Top
|
115
|
Wuhan Institute of Virology
|
12,267
|
395
|
C
|
Mid
|
116
|
Rabies virus
|
12,256
|
395
|
C
|
Top
|
117
|
Sin Nombre virus
|
12,218
|
394
|
B
|
High
|
118
|
Retrovirus
|
12,041
|
388
|
C
|
Top
|
119
|
Enterovirus
|
11,882
|
383
|
C
|
High
|
120
|
HIV/AIDS in the United States
|
11,860
|
382
|
C
|
Low
|
121
|
Roseola
|
11,473
|
370
|
C
|
High
|
122
|
Herpesviridae
|
11,217
|
361
|
C
|
Top
|
123
|
Interferon
|
10,994
|
354
|
B
|
Top
|
124
|
SV40
|
10,924
|
352
|
C
|
Mid
|
125
|
Feline leukemia virus
|
10,901
|
351
|
C
|
High
|
126
|
Coxsackievirus
|
10,675
|
344
|
C
|
High
|
127
|
Adenoviridae
|
10,599
|
341
|
B
|
High
|
128
|
Vaccination
|
10,318
|
332
|
B
|
Top
|
129
|
Japanese encephalitis
|
10,255
|
330
|
B
|
High
|
130
|
SARS-CoV-2 Omicron variant
|
10,230
|
330
|
C
|
High
|
131
|
Zika virus
|
10,091
|
325
|
B
|
Top
|
132
|
Gain-of-function research
|
9,886
|
318
|
C
|
High
|
133
|
Compartmental models in epidemiology
|
9,745
|
314
|
C
|
Mid
|
134
|
Vaccine hesitancy
|
9,559
|
308
|
B
|
High
|
135
|
COVID-19 pandemic in Australia
|
9,519
|
307
|
B
|
Low
|
136
|
Measles virus
|
9,501
|
306
|
C
|
Top
|
137
|
COVID-19 pandemic in the Philippines
|
9,430
|
304
|
B
|
Low
|
138
|
Viral hemorrhagic fever
|
9,421
|
303
|
C
|
High
|
139
|
Moderna
|
9,280
|
299
|
C
|
Low
|
140
|
Zaire ebolavirus
|
9,189
|
296
|
C
|
Top
|
141
|
Feline immunodeficiency virus
|
9,039
|
291
|
C
|
High
|
142
|
Index case
|
9,022
|
291
|
Start
|
Low
|
143
|
Human coronavirus OC43
|
9,015
|
290
|
C
|
Mid
|
144
|
Feline infectious peritonitis
|
9,003
|
290
|
C
|
High
|
145
|
Western African Ebola epidemic
|
8,961
|
289
|
GA
|
Mid
|
146
|
2020–2025 H5N1 outbreak
|
8,903
|
287
|
C
|
Low
|
147
|
Virus classification
|
8,872
|
286
|
C
|
Top
|
148
|
New York COVID-19 nursing home scandal
|
8,715
|
281
|
B
|
Low
|
149
|
Lassa virus
|
8,614
|
277
|
C
|
Mid
|
150
|
Obelisk (biology)
|
8,571
|
276
|
Start
|
High
|
151
|
SARS-CoV-1
|
8,272
|
266
|
C
|
High
|
152
|
Timeline of HIV/AIDS
|
8,268
|
266
|
List
|
Mid
|
153
|
Myxomatosis
|
8,239
|
265
|
GA
|
High
|
154
|
COVID-19 pandemic in Canada
|
8,200
|
264
|
B
|
Mid
|
155
|
1889–1890 pandemic
|
8,167
|
263
|
C
|
Mid
|
156
|
Rabies in animals
|
8,123
|
262
|
C
|
High
|
157
|
Feline calicivirus
|
8,021
|
258
|
C
|
Top
|
158
|
Tobacco mosaic virus
|
8,004
|
258
|
C
|
High
|
159
|
Poliovirus
|
7,766
|
250
|
GA
|
High
|
160
|
Koplik's spots
|
7,601
|
245
|
C
|
Mid
|
161
|
Nipah virus
|
7,553
|
243
|
Start
|
Mid
|
162
|
Hong Kong flu
|
7,532
|
242
|
C
|
Low
|
163
|
Alphapithovirus
|
7,463
|
240
|
C
|
High
|
164
|
Swine influenza
|
7,425
|
239
|
B
|
High
|
165
|
2001 United Kingdom foot-and-mouth outbreak
|
7,328
|
236
|
C
|
Mid
|
166
|
Influenza vaccine
|
7,185
|
231
|
B
|
Top
|
167
|
2019 Samoa measles outbreak
|
7,099
|
229
|
C
|
Low
|
168
|
Parvovirus B19
|
7,090
|
228
|
C
|
Mid
|
169
|
COVID-19 pandemic in mainland China
|
7,074
|
228
|
C
|
High
|
170
|
Variants of SARS-CoV-2
|
7,005
|
225
|
C
|
Mid
|
171
|
COVID-19 pandemic in New Zealand
|
6,982
|
225
|
C
|
Low
|
172
|
COVID-19 pandemic in the Republic of Ireland
|
6,959
|
224
|
C
|
Low
|
173
|
Tick-borne encephalitis
|
6,618
|
213
|
Start
|
Low
|
174
|
COVID-19 pandemic in Victoria
|
6,547
|
211
|
C
|
Low
|
175
|
1978 smallpox outbreak in the United Kingdom
|
6,529
|
210
|
B
|
Low
|
176
|
Orthomyxoviridae
|
6,456
|
208
|
B
|
High
|
177
|
Viral disease
|
6,439
|
207
|
List
|
Top
|
178
|
Disease X
|
6,425
|
207
|
GA
|
Low
|
179
|
COVID-19 pandemic in Maharashtra
|
6,396
|
206
|
C
|
Low
|
180
|
Human herpesvirus 6
|
6,339
|
204
|
C
|
High
|
181
|
1977 Russian flu
|
6,282
|
202
|
C
|
Mid
|
182
|
RNA interference
|
6,246
|
201
|
FA
|
High
|
183
|
Respiratory syncytial virus vaccine
|
6,224
|
200
|
B
|
Mid
|
184
|
Human T-lymphotropic virus 1
|
6,215
|
200
|
C
|
High
|
185
|
DNA polymerase
|
6,102
|
196
|
C
|
Top
|
186
|
Lyssavirus
|
6,049
|
195
|
C
|
Mid
|
187
|
Merkel-cell carcinoma
|
6,049
|
195
|
C
|
Mid
|
188
|
Lady Mary Wortley Montagu
|
5,979
|
192
|
B
|
Low
|
189
|
COVID-19 vaccination mandates in the United States
|
5,972
|
192
|
Start
|
Low
|
190
|
Cowpox
|
5,971
|
192
|
C
|
Mid
|
191
|
Viroid
|
5,935
|
191
|
C
|
High
|
192
|
MERS
|
5,910
|
190
|
B
|
High
|
193
|
Dengue virus
|
5,891
|
190
|
B
|
Top
|
194
|
Peter Daszak
|
5,824
|
187
|
Start
|
Low
|
195
|
Human parainfluenza viruses
|
5,822
|
187
|
C
|
Mid
|
196
|
Papillomaviridae
|
5,803
|
187
|
B
|
Top
|
197
|
Polio eradication
|
5,788
|
186
|
B
|
Mid
|
198
|
Subtypes of HIV
|
5,787
|
186
|
C
|
High
|
199
|
Economic impact of the COVID-19 pandemic
|
5,773
|
186
|
B
|
Low
|
200
|
Marburg virus disease
|
5,751
|
185
|
C
|
High
|
201
|
Incertae sedis
|
5,669
|
182
|
C
|
Low
|
202
|
Yellow fever vaccine
|
5,645
|
182
|
C
|
High
|
203
|
Timeline of the COVID-19 pandemic in March 2020
|
5,433
|
175
|
List
|
High
|
204
|
Bioterrorism
|
5,430
|
175
|
B
|
Low
|
205
|
Xenophobia and racism related to the COVID-19 pandemic
|
5,373
|
173
|
List
|
Low
|
206
|
Host (biology)
|
5,371
|
173
|
GA
|
High
|
207
|
History of COVID-19 vaccine development
|
5,352
|
172
|
C
|
Low
|
208
|
Timeline of the COVID-19 pandemic in 2019
|
5,310
|
171
|
List
|
High
|
209
|
Variolation
|
5,306
|
171
|
C
|
High
|
210
|
Malaysian movement control order
|
5,233
|
168
|
B
|
Low
|
211
|
Reverse transcriptase
|
5,224
|
168
|
B
|
Top
|
212
|
RNA virus
|
5,202
|
167
|
B
|
High
|
213
|
Severe acute respiratory syndrome coronavirus 2
|
5,189
|
167
|
Redirect
|
NA
|
214
|
Lentivirus
|
5,177
|
167
|
C
|
Mid
|
215
|
Attenuated vaccine
|
5,130
|
165
|
C
|
High
|
216
|
Viral hepatitis
|
5,112
|
164
|
C
|
High
|
217
|
Phage therapy
|
5,090
|
164
|
C
|
Top
|
218
|
COVID-19 vaccine misinformation and hesitancy
|
5,082
|
163
|
B
|
Top
|
219
|
Ebolavirus
|
5,027
|
162
|
C
|
Mid
|
220
|
Herpes simplex encephalitis
|
5,024
|
162
|
Start
|
Low
|
221
|
Impact of the COVID-19 pandemic on cinema
|
5,001
|
161
|
B
|
Low
|
222
|
Ebola virus cases in the United States
|
4,973
|
160
|
C
|
High
|
223
|
Dengue vaccine
|
4,960
|
160
|
C
|
Low
|
224
|
Walter Reed
|
4,957
|
159
|
C
|
Low
|
225
|
Henipavirus
|
4,955
|
159
|
C
|
High
|
226
|
Hepatitis B virus
|
4,869
|
157
|
C
|
Top
|
227
|
COVID-19 pandemic in Italy
|
4,838
|
156
|
C
|
Mid
|
228
|
Adeno-associated virus
|
4,837
|
156
|
B
|
High
|
229
|
Crimean–Congo hemorrhagic fever
|
4,798
|
154
|
C
|
High
|
230
|
Astrovirus
|
4,798
|
154
|
B
|
Low
|
231
|
Reston virus
|
4,787
|
154
|
C
|
Low
|
232
|
Vaccine shedding
|
4,781
|
154
|
Start
|
Mid
|
233
|
COVID-19 vaccination in the United States
|
4,769
|
153
|
Start
|
Low
|
234
|
Hershey–Chase experiment
|
4,754
|
153
|
C
|
Mid
|
235
|
Filoviridae
|
4,685
|
151
|
Start
|
High
|
236
|
RNA polymerase
|
4,656
|
150
|
B
|
High
|
237
|
COVID-19 pandemic in North Korea
|
4,629
|
149
|
B
|
Mid
|
238
|
Hepatitis C virus
|
4,602
|
148
|
B
|
Top
|
239
|
Parvoviridae
|
4,565
|
147
|
B
|
Mid
|
240
|
Pithovirus
|
4,545
|
146
|
Redirect
|
NA
|
241
|
Virology
|
4,511
|
145
|
B
|
Top
|
242
|
COVID-19 pandemic in South Africa
|
4,498
|
145
|
B
|
Mid
|
243
|
Human polyomavirus 2
|
4,497
|
145
|
C
|
High
|
244
|
Rotavirus vaccine
|
4,478
|
144
|
C
|
High
|
245
|
Human coronavirus HKU1
|
4,460
|
143
|
C
|
High
|
246
|
Timeline of human vaccines
|
4,442
|
143
|
List
|
Low
|
247
|
U.S. state and local government responses to the COVID-19 pandemic
|
4,434
|
143
|
C
|
Mid
|
248
|
Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020)
|
4,434
|
143
|
List
|
Low
|
249
|
MERS-related coronavirus
|
4,422
|
142
|
B
|
High
|
250
|
Poxviridae
|
4,415
|
142
|
C
|
High
|
251
|
Ivermectin during the COVID-19 pandemic
|
4,401
|
141
|
B
|
Low
|
252
|
COVID-19 testing
|
4,398
|
141
|
B
|
Low
|
253
|
Adenovirus infection
|
4,392
|
141
|
C
|
Mid
|
254
|
Escherichia virus T4
|
4,362
|
140
|
Start
|
Mid
|
255
|
Hepatitis E
|
4,348
|
140
|
GA
|
High
|
256
|
Pandemic H1N1/09 virus
|
4,337
|
139
|
C
|
Mid
|
257
|
Face masks during the COVID-19 pandemic
|
4,329
|
139
|
C
|
Low
|
258
|
COVID-19 pandemic in New York City
|
4,302
|
138
|
C
|
Low
|
259
|
Marek's disease
|
4,283
|
138
|
C
|
Mid
|
260
|
Foot-and-mouth disease virus
|
4,261
|
137
|
Start
|
Mid
|
261
|
Influenza pandemic
|
4,259
|
137
|
B
|
Top
|
262
|
Hantaan virus
|
4,235
|
136
|
B
|
Low
|
263
|
Spike protein
|
4,216
|
136
|
Start
|
Low
|
264
|
Lambda phage
|
4,207
|
135
|
B
|
High
|
265
|
Negative-strand RNA virus
|
4,205
|
135
|
B
|
Mid
|
266
|
Viral encephalitis
|
4,175
|
134
|
B
|
High
|
267
|
Flavivirus
|
4,168
|
134
|
B
|
High
|
268
|
West Nile fever
|
4,163
|
134
|
C
|
High
|
269
|
Viral envelope
|
4,119
|
132
|
Start
|
Top
|
270
|
Shope papilloma virus
|
4,113
|
132
|
C
|
Mid
|
271
|
Non-cellular life
|
4,112
|
132
|
Start
|
Low
|
272
|
Symptoms of COVID-19
|
4,097
|
132
|
C
|
Low
|
273
|
Hantaviridae
|
4,083
|
131
|
Stub
|
Mid
|
274
|
Paramyxoviridae
|
4,057
|
130
|
C
|
High
|
275
|
Capsid
|
4,055
|
130
|
C
|
Top
|
276
|
COVID-19 pandemic in New South Wales
|
4,049
|
130
|
B
|
Low
|
277
|
List of films impacted by the COVID-19 pandemic
|
4,030
|
130
|
List
|
Mid
|
278
|
Impact of the COVID-19 pandemic on education
|
4,020
|
129
|
C
|
Low
|
279
|
History of virology
|
3,996
|
128
|
B
|
Top
|
280
|
Sapovirus
|
3,992
|
128
|
C
|
High
|
281
|
Lysogenic cycle
|
3,989
|
128
|
C
|
High
|
282
|
Australian bat lyssavirus
|
3,980
|
128
|
C
|
Low
|
283
|
Monkeypox virus
|
3,952
|
127
|
C
|
Mid
|
284
|
Congenital rubella syndrome
|
3,938
|
127
|
Start
|
Mid
|
285
|
Carcinogenesis
|
3,922
|
126
|
B
|
Mid
|
286
|
Coxsackie A virus
|
3,897
|
125
|
Start
|
Mid
|
287
|
Rabbit hemorrhagic disease
|
3,849
|
124
|
B
|
Mid
|
288
|
BK virus
|
3,814
|
123
|
B
|
Low
|
289
|
Rubella virus
|
3,812
|
122
|
C
|
High
|
290
|
Hepatitis D
|
3,791
|
122
|
C
|
Mid
|
291
|
Timeline of the COVID-19 pandemic in Canada
|
3,770
|
121
|
B
|
Mid
|
292
|
DNA virus
|
3,749
|
120
|
C
|
Top
|
293
|
1957–1958 influenza pandemic
|
3,745
|
120
|
C
|
Mid
|
294
|
Diagnosis of HIV/AIDS
|
3,731
|
120
|
B
|
High
|
295
|
Kaposi's sarcoma-associated herpesvirus
|
3,716
|
119
|
C
|
High
|
296
|
Oncovirus
|
3,714
|
119
|
C
|
Top
|
297
|
White House Coronavirus Task Force
|
3,714
|
119
|
C
|
Low
|
298
|
Metagenomics
|
3,697
|
119
|
GA
|
High
|
299
|
Coronavirus spike protein
|
3,695
|
119
|
Start
|
Low
|
300
|
SARS-CoV-2 Delta variant
|
3,675
|
118
|
C
|
Mid
|
301
|
Eastern equine encephalitis
|
3,664
|
118
|
B
|
Mid
|
302
|
Simian immunodeficiency virus
|
3,644
|
117
|
C
|
High
|
303
|
Viral pneumonia
|
3,644
|
117
|
C
|
High
|
304
|
Eczema herpeticum
|
3,644
|
117
|
Start
|
Low
|
305
|
Oropouche fever
|
3,636
|
117
|
C
|
Low
|
306
|
Virulent Newcastle disease
|
3,624
|
116
|
C
|
High
|
307
|
Virulence
|
3,598
|
116
|
C
|
High
|
308
|
Sense (molecular biology)
|
3,597
|
116
|
C
|
High
|
309
|
COVID-19 pandemic in Japan
|
3,597
|
116
|
C
|
Low
|
310
|
Natural reservoir
|
3,585
|
115
|
C
|
High
|
311
|
Orthopoxvirus
|
3,545
|
114
|
C
|
High
|
312
|
COVID-19 pandemic in Europe
|
3,537
|
114
|
C
|
Low
|
313
|
Transduction (genetics)
|
3,519
|
113
|
C
|
High
|
314
|
B virus
|
3,506
|
113
|
C
|
Mid
|
315
|
Influenza A virus subtype H3N2
|
3,485
|
112
|
C
|
High
|
316
|
List of Ebola outbreaks
|
3,478
|
112
|
List
|
Low
|
317
|
COVID-19 pandemic in Sweden
|
3,463
|
111
|
B
|
Low
|
318
|
Vaccinia
|
3,460
|
111
|
C
|
High
|
319
|
COVID-19 pandemic in Singapore
|
3,452
|
111
|
B
|
High
|
320
|
Human cytomegalovirus
|
3,433
|
110
|
C
|
High
|
321
|
HIV/AIDS in Russia
|
3,419
|
110
|
Start
|
Low
|
322
|
2023–2025 mpox epidemic
|
3,419
|
110
|
C
|
Mid
|
323
|
Smallpox virus retention debate
|
3,402
|
109
|
Start
|
Low
|
324
|
Global spread of H5N1
|
3,363
|
108
|
B
|
High
|
325
|
Flat wart
|
3,348
|
108
|
Stub
|
Mid
|
326
|
List of biosafety level 4 organisms
|
3,343
|
107
|
List
|
Low
|
327
|
Travel during the COVID-19 pandemic
|
3,325
|
107
|
C
|
Low
|
328
|
Echovirus
|
3,310
|
106
|
List
|
Mid
|
329
|
Positive-strand RNA virus
|
3,306
|
106
|
C
|
High
|
330
|
Impact of the COVID-19 pandemic on sports
|
3,271
|
105
|
C
|
Mid
|
331
|
Hammer-headed bat
|
3,258
|
105
|
GA
|
Low
|
332
|
Baltimore classification
|
3,248
|
104
|
B
|
Top
|
333
|
Timeline of the COVID-19 pandemic in New Zealand (2020)
|
3,238
|
104
|
List
|
Low
|
334
|
Hendra virus
|
3,235
|
104
|
Start
|
Mid
|
335
|
Picornavirus
|
3,217
|
103
|
B
|
Mid
|
336
|
Human coronavirus NL63
|
3,213
|
103
|
C
|
Low
|
337
|
Virgin cleansing myth
|
3,184
|
102
|
Start
|
Low
|
338
|
Nipah virus infection
|
3,170
|
102
|
C
|
High
|
339
|
African swine fever virus
|
3,168
|
102
|
C
|
High
|
340
|
COVID-19 vaccination in India
|
3,165
|
102
|
C
|
Low
|
341
|
COVID-19 pandemic in Tamil Nadu
|
3,152
|
101
|
C
|
Low
|
342
|
Ebola virus
|
3,132
|
101
|
Redirect
|
NA
|
343
|
Bluetongue disease
|
3,103
|
100
|
B
|
High
|
344
|
COVID-19 pandemic on cruise ships
|
3,103
|
100
|
B
|
High
|
345
|
Lytic cycle
|
3,102
|
100
|
C
|
High
|
346
|
Riboviria
|
3,101
|
100
|
B
|
Top
|
347
|
HIV vaccine development
|
3,100
|
100
|
C
|
Mid
|
348
|
Mumps virus
|
3,099
|
99
|
B
|
High
|
349
|
Giant virus
|
3,088
|
99
|
C
|
High
|
350
|
COVID-19 lockdown in China
|
3,087
|
99
|
C
|
High
|
351
|
Endogenous retrovirus
|
3,070
|
99
|
C
|
Mid
|
352
|
COVID-19 pandemic in Russia
|
3,067
|
98
|
C
|
Low
|
353
|
Zika fever
|
3,042
|
98
|
B
|
High
|
354
|
Rhabdoviridae
|
3,031
|
97
|
C
|
High
|
355
|
Viral evolution
|
3,030
|
97
|
C
|
High
|
356
|
Epstein–Barr virus–associated lymphoproliferative diseases
|
3,030
|
97
|
C
|
Mid
|
357
|
COVID-19 pandemic in Delhi
|
3,021
|
97
|
C
|
Low
|
358
|
GS-441524
|
3,019
|
97
|
Start
|
Low
|
359
|
Feline coronavirus
|
3,001
|
96
|
C
|
Mid
|
360
|
Timeline of the COVID-19 pandemic in New York City
|
3,000
|
96
|
C
|
Low
|
361
|
Ebola vaccine
|
2,996
|
96
|
C
|
Mid
|
362
|
2022–2023 mpox outbreak
|
2,983
|
96
|
B
|
Mid
|
363
|
Feed a cold, starve a fever
|
2,944
|
94
|
C
|
Low
|
364
|
Rift Valley fever
|
2,941
|
94
|
C
|
High
|
365
|
Strain (biology)
|
2,937
|
94
|
C
|
High
|
366
|
SARS-related coronavirus
|
2,915
|
94
|
C
|
High
|
367
|
Measles morbillivirus
|
2,907
|
93
|
Redirect
|
NA
|
368
|
Spillover infection
|
2,905
|
93
|
Start
|
Mid
|
369
|
Impact of the COVID-19 pandemic on the environment
|
2,889
|
93
|
C
|
Low
|
370
|
Impact of the COVID-19 pandemic on the video game industry
|
2,886
|
93
|
C
|
Low
|
371
|
Chinese government response to COVID-19
|
2,886
|
93
|
B
|
Mid
|
372
|
COVID-19 pandemic on Diamond Princess
|
2,881
|
92
|
Start
|
Low
|
373
|
Shi Zhengli
|
2,861
|
92
|
Start
|
Low
|
374
|
Phage display
|
2,857
|
92
|
C
|
Mid
|
375
|
Lipid-based nanoparticle
|
2,849
|
91
|
C
|
Low
|
376
|
Caliciviridae
|
2,844
|
91
|
C
|
Mid
|
377
|
HMPV seasonal outbreak in China (2024)
|
2,844
|
91
|
C
|
Low
|
378
|
Flu season
|
2,840
|
91
|
C
|
High
|
379
|
Face masks during the COVID-19 pandemic in the United States
|
2,826
|
91
|
C
|
Low
|
380
|
COVID-19 pandemic in California
|
2,811
|
90
|
C
|
Mid
|
381
|
Discrimination against people with HIV/AIDS
|
2,775
|
89
|
C
|
High
|
382
|
MOG antibody disease
|
2,775
|
89
|
C
|
Mid
|
383
|
Timeline of the COVID-19 pandemic in the Republic of Ireland (2020)
|
2,753
|
88
|
C
|
Low
|
384
|
Polyomaviridae
|
2,751
|
88
|
C
|
High
|
385
|
1793 Philadelphia yellow fever epidemic
|
2,725
|
87
|
C
|
Low
|
386
|
Bat virome
|
2,722
|
87
|
GA
|
High
|
387
|
Timeline of the COVID-19 pandemic in January 2020
|
2,719
|
87
|
List
|
High
|
388
|
Arbovirus
|
2,712
|
87
|
C
|
Top
|
389
|
U.S. federal government response to the COVID-19 pandemic
|
2,692
|
86
|
C
|
Mid
|
390
|
Vaccine misinformation
|
2,691
|
86
|
C
|
Mid
|
391
|
Viral shedding
|
2,681
|
86
|
Start
|
High
|
392
|
COVID-19 pandemic in New York (state)
|
2,674
|
86
|
C
|
Low
|
393
|
Disneyland measles outbreak
|
2,674
|
86
|
Start
|
Low
|
394
|
COVID-19 pandemic in Kerala
|
2,653
|
85
|
C
|
Low
|
395
|
HIV trial in Libya
|
2,628
|
84
|
B
|
Low
|
396
|
2020–21 Singapore circuit breaker measures
|
2,611
|
84
|
C
|
Low
|
397
|
Jonathan Van-Tam
|
2,607
|
84
|
C
|
Low
|
398
|
Oncolytic virus
|
2,590
|
83
|
B
|
Mid
|
399
|
Metapneumovirus
|
2,586
|
83
|
Stub
|
Mid
|
400
|
Influenza A virus subtype H7N9
|
2,585
|
83
|
B
|
High
|
401
|
Orthornavirae
|
2,578
|
83
|
B
|
High
|
402
|
Virion
|
2,559
|
82
|
Start
|
Top
|
403
|
RNA-dependent RNA polymerase
|
2,535
|
81
|
C
|
Top
|
404
|
HBsAg
|
2,491
|
80
|
Start
|
High
|
405
|
Rolling circle replication
|
2,488
|
80
|
C
|
Mid
|
406
|
H5N1 vaccine
|
2,484
|
80
|
C
|
Low
|
407
|
Viral replication
|
2,481
|
80
|
C
|
Top
|
408
|
COVID-19 pandemic in Hong Kong
|
2,469
|
79
|
C
|
Low
|
409
|
COVID-19 pandemic in Brazil
|
2,469
|
79
|
C
|
Low
|
410
|
Deployment of COVID-19 vaccines
|
2,459
|
79
|
C
|
High
|
411
|
Enhanced community quarantine in Luzon
|
2,426
|
78
|
B
|
Low
|
412
|
Vertically transmitted infection
|
2,420
|
78
|
C
|
High
|
413
|
Human bocavirus
|
2,410
|
77
|
C
|
Mid
|
414
|
Lymphocytic choriomeningitis
|
2,409
|
77
|
B
|
Mid
|
415
|
COVID-19 pandemic in Ontario
|
2,408
|
77
|
B
|
Low
|
416
|
List of unproven methods against COVID-19
|
2,398
|
77
|
List
|
Mid
|
417
|
Inclusion bodies
|
2,375
|
76
|
C
|
High
|
418
|
Impact of the COVID-19 pandemic on commercial air transport
|
2,363
|
76
|
C
|
Low
|
419
|
COVID-19 pandemic in Germany
|
2,349
|
75
|
C
|
Low
|
420
|
Molnupiravir
|
2,340
|
75
|
C
|
Mid
|
421
|
Bunyaviricetes
|
2,338
|
75
|
C
|
Mid
|
422
|
Superinfection
|
2,328
|
75
|
Stub
|
Mid
|
423
|
Orf (disease)
|
2,316
|
74
|
Start
|
Low
|
424
|
Superspreading event
|
2,295
|
74
|
C
|
High
|
425
|
Carnivore protoparvovirus 1
|
2,293
|
73
|
Start
|
Mid
|
426
|
COVID-19 pandemic in Hubei
|
2,263
|
73
|
C
|
Mid
|
427
|
Feline viral rhinotracheitis
|
2,262
|
72
|
C
|
Top
|
428
|
Emerging infectious disease
|
2,246
|
72
|
C
|
Low
|
429
|
Antibody-dependent enhancement
|
2,240
|
72
|
C
|
High
|
430
|
COVID-19 pandemic in Malaysia
|
2,213
|
71
|
B
|
High
|
431
|
Swedish government response to the COVID-19 pandemic
|
2,211
|
71
|
C
|
Low
|
432
|
2025 Uganda Ebola outbreak
|
2,201
|
71
|
Start
|
Low
|
433
|
Herpes simplex virus 2
|
2,193
|
70
|
Start
|
Mid
|
434
|
Innate resistance to HIV
|
2,190
|
70
|
C
|
High
|
435
|
COVID-19 pandemic in South Korea
|
2,164
|
69
|
B
|
Low
|
436
|
Viral vector vaccine
|
2,161
|
69
|
Start
|
Low
|
437
|
Primate T-lymphotropic virus
|
2,155
|
69
|
C
|
High
|
438
|
Intracellular parasite
|
2,146
|
69
|
Start
|
Mid
|
439
|
COVID-19 vaccination in the United Kingdom
|
2,134
|
68
|
C
|
Low
|
440
|
1976 Zaire Ebola virus outbreak
|
2,131
|
68
|
C
|
Low
|
441
|
COVID-19 pandemic in France
|
2,122
|
68
|
B
|
Mid
|
442
|
Coxsackie B virus
|
2,112
|
68
|
C
|
Mid
|
443
|
Flaviviridae
|
2,106
|
67
|
Start
|
High
|
444
|
Molluscum contagiosum virus
|
2,102
|
67
|
C
|
Mid
|
445
|
COVID-19 pandemic in Pakistan
|
2,096
|
67
|
B
|
Low
|
446
|
Human mortality from H5N1
|
2,094
|
67
|
C
|
High
|
447
|
SARS-CoV-2 Alpha variant
|
2,094
|
67
|
C
|
Low
|
448
|
Arenavirus
|
2,072
|
66
|
C
|
High
|
449
|
DNA vaccine
|
2,070
|
66
|
Start
|
Low
|
450
|
British government response to the COVID-19 pandemic
|
2,068
|
66
|
C
|
Low
|
451
|
Timeline of the COVID-19 pandemic in New Zealand (2021)
|
2,055
|
66
|
List
|
Low
|
452
|
Influenza C virus
|
2,053
|
66
|
C
|
Mid
|
453
|
Mimivirus
|
2,047
|
66
|
C
|
Mid
|
454
|
Alphavirus
|
2,040
|
65
|
B
|
Mid
|
455
|
History of coronavirus
|
2,032
|
65
|
B
|
Mid
|
456
|
Andes virus
|
2,029
|
65
|
B
|
Mid
|
457
|
COVID-19 pandemic in Florida
|
2,026
|
65
|
C
|
Low
|
458
|
Human herpesvirus 7
|
2,019
|
65
|
C
|
Mid
|
459
|
Virus latency
|
2,007
|
64
|
C
|
High
|
460
|
Human coronavirus 229E
|
1,996
|
64
|
Start
|
Mid
|
461
|
Ross River virus
|
1,989
|
64
|
C
|
Mid
|
462
|
Neil Ferguson (epidemiologist)
|
1,976
|
63
|
C
|
Mid
|
463
|
List of diseases of the honey bee
|
1,966
|
63
|
List
|
High
|
464
|
Lamivudine
|
1,957
|
63
|
C
|
Mid
|
465
|
2019 New York measles outbreak
|
1,956
|
63
|
C
|
Low
|
466
|
Pleomorphism (microbiology)
|
1,943
|
62
|
C
|
High
|
467
|
Neurotropic virus
|
1,941
|
62
|
Start
|
High
|
468
|
Structure and genome of HIV
|
1,936
|
62
|
B
|
High
|
469
|
History of the COVID-19 pandemic in the United Kingdom
|
1,936
|
62
|
C
|
High
|
470
|
Viral load
|
1,921
|
61
|
Start
|
Mid
|
471
|
Pipistrellus bat coronavirus HKU5
|
1,918
|
61
|
Start
|
Low
|
472
|
Baculoviridae
|
1,902
|
61
|
C
|
Mid
|
473
|
Timeline of the COVID-19 pandemic in the United Kingdom
|
1,895
|
61
|
List
|
Low
|
474
|
2015–16 Zika virus epidemic
|
1,894
|
61
|
B
|
Mid
|
475
|
Timeline of the COVID-19 pandemic in England (2022)
|
1,891
|
61
|
List
|
Low
|
476
|
COVID-19 pandemic in North America
|
1,886
|
60
|
C
|
Mid
|
477
|
COVID-19 pandemic in Ukraine
|
1,886
|
60
|
Start
|
Low
|
478
|
Introduction to viruses
|
1,885
|
60
|
FA
|
Top
|
479
|
Richard H. Ebright
|
1,870
|
60
|
Start
|
Mid
|
480
|
Herpes simplex virus 1
|
1,861
|
60
|
Start
|
Mid
|
481
|
Coalition for Epidemic Preparedness Innovations
|
1,839
|
59
|
GA
|
Low
|
482
|
Hantavirus vaccine
|
1,837
|
59
|
Start
|
High
|
483
|
COVID-19 pandemic in Spain
|
1,828
|
58
|
C
|
Low
|
484
|
European respirator standards
|
1,822
|
58
|
C
|
Mid
|
485
|
Dobrava-Belgrade virus
|
1,820
|
58
|
B
|
Mid
|
486
|
Communication of the Trump administration during the COVID-19 pandemic
|
1,817
|
58
|
C
|
Low
|
487
|
Coronaviridae
|
1,806
|
58
|
Start
|
High
|
488
|
Puumala virus
|
1,805
|
58
|
B
|
Low
|
489
|
Natal multimammate mouse
|
1,788
|
57
|
Start
|
Low
|
490
|
Plant virus
|
1,770
|
57
|
C
|
Top
|
491
|
Reverse-transcriptase inhibitor
|
1,769
|
57
|
C
|
High
|
492
|
PEGylation
|
1,767
|
57
|
C
|
Low
|
493
|
Morbillivirus
|
1,762
|
56
|
C
|
Mid
|
494
|
Banana bunchy top virus
|
1,739
|
56
|
C
|
Mid
|
495
|
Oropouche virus
|
1,734
|
55
|
Start
|
Mid
|
496
|
Virophage
|
1,729
|
55
|
C
|
Mid
|
497
|
1916 New York City polio epidemic
|
1,720
|
55
|
B
|
Low
|
498
|
Heterophile antibody test
|
1,712
|
55
|
C
|
Low
|
499
|
Tulip breaking virus
|
1,709
|
55
|
C
|
High
|
500
|
Psittacine beak and feather disease
|
1,702
|
54
|
Start
|
Mid
|